Two biotechs launch public offerings; Vaxxinity shares safety data on its Parkinson's vaccine
Two biotechs are turning to public offerings to get more cash.
California-based IGM Biosciences will be selling some of its stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
